Tag: Cancer: Misc.
American Society of Clinical Oncology, June 2-6
The 53rd Annual Meeting of the American Society of Clinical Oncology The annual meeting of the American Society of Clinical Oncology...
ASCO: Agreement Lacking With ESMO on Most Effective Drugs
Negative correlation identified for ASCO benefit score with monthly incremental drug costs
ASCO: SWOG Trials Have Had Considerable Impact on Cancer
Estimated 3.34 million life-years gained through 2015 from 23 positive SWOG treatment trials
ASCO: Industry Perks Influence Physicians’ Choice of Cancer Rx
Even relatively small payments appear to make a difference, researchers say
ASCO: Single Radiation Tx Enough for Spinal Pain in Cancer Mets
Researchers suggest it works as well as a full week of treatments
ASCO: Survival Up With Patient-Reported Outcomes During CA Tx
Improved survival with patient-reported outcomes for symptom monitoring in metastatic cancer
ASCO: Gene-Targeted Drug Shows Efficacy for Child, Adult Cancers
Larotrectinib targets tropomyosin receptor kinase fusion proteins
May 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for May 2017. This roundup includes...
Concerns Limit Hospice Use for Hematologic Oncologists
Almost half of respondents felt that home hospice was inadequate for their patients' needs
Technology Can Help Patients Facing Routine Decisions
Use of technology makes appointments more productive, helps patients engage in the decision
